Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 55 | 0 | 0 |
| Gross Profit | N/A | N/A | 55 | 0 | N/A |
| Operating Expenses | 4,885 | 7,731 | 5,285 | 4,561 | 4,751 |
| Operating Income | -4,885 | -7,731 | -5,230 | -4,561 | -4,751 |
| Other Income | 188 | 70 | 109 | -35 | 197 |
| Pre-tax Income | -4,697 | -7,661 | -5,121 | -4,596 | -4,554 |
| Income Tax | 22 | 27 | 17 | 78 | 4 |
| Net Income Continuous | -4,718 | -7,688 | -5,137 | -4,675 | -4,558 |
| Net Income | $-4,718 | $-7,688 | $-5,137 | $-4,675 | $-4,558 |
| EPS Basic Total Ops | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 |
| EPS Basic Continuous Ops | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 |
| EPS Diluted Total Ops | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 |
| EPS Diluted Continuous Ops | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 |
| EBITDA(a) | $-4,865 | $-7,711 | $-5,211 | $-4,543 | $-4,733 |